Thyroid hormone excess and osteoporosis

Acta Med Austriaca. 1994;21(2):65-7.

Abstract

Current thinking and available clinical data on the relationship between hyperthyroidism and bone disease are discussed. Data are also presented on TSH-suppressive and non-suppressive thyroid hormone therapy and its effect on bone. Although these data are clearly inconsistent, some risk factors for thyroid hormone induced osteopenia seem to be accepted: long standing, clinically manifest hyperthyroidism (a very rare disorder today because of early diagnosis and appropriate therapy), old age, menopause and total thyroidectomy. Thyroid hormone therapy (whether TSH-suppressive or not) has not been proven so far to lead to manifest osteoporosis.

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Antithyroid Agents / adverse effects
  • Antithyroid Agents / therapeutic use
  • Bone Diseases, Metabolic / chemically induced
  • Bone Diseases, Metabolic / physiopathology
  • Female
  • Humans
  • Hyperthyroidism / chemically induced
  • Hyperthyroidism / physiopathology*
  • Male
  • Middle Aged
  • Osteoporosis / chemically induced
  • Osteoporosis / physiopathology*
  • Risk Factors
  • Thyroid Hormones / physiology
  • Thyrotropin / antagonists & inhibitors
  • Thyrotropin / physiology

Substances

  • Antithyroid Agents
  • Thyroid Hormones
  • Thyrotropin